Keywords: hana, initiates, ph, ii, marqibo, aml, study

Hana initiates Ph II Marqibo AML study

Article | 13 August 2007

Canadian biopharmaceutical firm Tekmira Pharmaceuticals says that USA-based partner Hana Biosciences has initiated a Phase II clinical trial of Marqibo ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing